Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population

Pulmonary Embolism Clinical Trial

Official title:

Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02214043
• Other study ID #: APEINCP
• Status: Completed
• Phase: N/A
• First received: February 3, 2014
• Last updated: January 28, 2018
• Start date: January 2012
• Est. completion date: December 2017

Study information

• Verified date: July 2016
• Source: Chinese Pulmonary Vascular Disease Research Group
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

There are no special clinical characteristics of acute pulmonary embolism in Chinese population.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 600
• Est. completion date: December 2017
• Est. primary completion date: December 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 15 Years to 85 Years

Eligibility

Inclusion Criteria:

• the symptomatic acute PE confirmed by objective examination

Exclusion Criteria:

• congestive heart failure

• chronic obstructive pulmonary disease;

• a prior documented episode of PE or DVT

• renal dysfunction;

• a life expectancy of less than 6 months

Related Conditions & MeSH terms

• Embolism
• Pulmonary Embolism

Locations

Country	Name	City	State
China	Center of pumonary vascular diseases	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Chinese Pulmonary Vascular Disease Research Group

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The primary end point of the present study was symptomatic, objectively confirmed recurrent fatal or nonfatal VTE.		60 months
Secondary	The second end point was death (all cause death and PE-related death).	If the participant died, the relatives need provided the written medical record on the death.	60 months